Short Interest in National Health Investors, Inc. (NYSE:NHI) Grows By 102.4%

National Health Investors, Inc. (NYSE:NHI) was the recipient of a significant increase in short interest during the month of June. As of June 30th, there was short interest totaling 3,740,952 shares, an increase of 102.4% from the June 15th total of 1,847,936 shares. Approximately 7.9% of the shares of the company are short sold. Based on an average trading volume of 1,574,464 shares, the days-to-cover ratio is presently 2.4 days.

Analyst Ratings Changes

Several research firms recently issued reports on NHI. Truist Financial reduced their price target on shares of National Health Investors from $89.00 to $81.00 and set a “buy” rating on the stock in a research report on Friday, June 12th. Cantor Fitzgerald restated an “overweight” rating and set a $94.00 target price on shares of National Health Investors in a research note on Wednesday, April 22nd. Wells Fargo & Company reduced their target price on National Health Investors from $84.00 to $79.00 and set an “equal weight” rating on the stock in a report on Monday, June 1st. BMO Capital Markets decreased their price target on National Health Investors from $90.00 to $80.00 and set an “outperform” rating on the stock in a research note on Monday, June 15th. Finally, Weiss Ratings cut National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a report on Friday, June 12th. Five investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $83.86.

Insider Transactions at National Health Investors

In other news, Director Robert A. Mccabe, Jr. purchased 890 shares of National Health Investors stock in a transaction that occurred on Monday, June 15th. The stock was acquired at an average cost of $71.65 per share, for a total transaction of $63,768.50. Following the purchase, the director directly owned 44,159 shares of the company’s stock, valued at $3,163,992.35. This trade represents a 2.06% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO D. Eric Mendelsohn bought 1,500 shares of National Health Investors stock in a transaction dated Friday, June 5th. The stock was acquired at an average cost of $68.84 per share, with a total value of $103,260.00. Following the transaction, the chief executive officer owned 133,316 shares of the company’s stock, valued at $9,177,473.44. This trade represents a 1.14% increase in their position. The SEC filing for this purchase provides additional information. Company insiders own 2.70% of the company’s stock.

Institutional Trading of National Health Investors

A number of institutional investors and hedge funds have recently modified their holdings of the business. Moody National Bank Trust Division purchased a new stake in National Health Investors in the second quarter worth $723,000. Pensionfund PDN lifted its position in shares of National Health Investors by 74.3% during the 2nd quarter. Pensionfund PDN now owns 12,200 shares of the real estate investment trust’s stock valued at $930,000 after buying an additional 5,200 shares during the last quarter. Pensionfund Sabic grew its stake in shares of National Health Investors by 71.4% during the 2nd quarter. Pensionfund Sabic now owns 6,000 shares of the real estate investment trust’s stock worth $458,000 after acquiring an additional 2,500 shares during the period. Militia Capital Management LLC bought a new position in shares of National Health Investors during the 1st quarter worth $2,458,000. Finally, NewEdge Advisors LLC increased its holdings in National Health Investors by 18.1% in the 1st quarter. NewEdge Advisors LLC now owns 12,046 shares of the real estate investment trust’s stock worth $974,000 after acquiring an additional 1,844 shares during the last quarter. 62.51% of the stock is owned by hedge funds and other institutional investors.

National Health Investors Trading Up 0.8%

Shares of NYSE NHI traded up $0.62 during trading on Friday, reaching $79.76. The company had a trading volume of 414,789 shares, compared to its average volume of 443,122. The company’s fifty day moving average price is $74.36 and its 200-day moving average price is $79.60. National Health Investors has a 12 month low of $67.94 and a 12 month high of $91.38. The stock has a market cap of $3.87 billion, a P/E ratio of 25.73, a PEG ratio of 3.40 and a beta of 0.51. The company has a quick ratio of 8.20, a current ratio of 8.20 and a debt-to-equity ratio of 0.83.

National Health Investors Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 7th. Shareholders of record on Tuesday, June 30th will be paid a $0.92 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $3.68 annualized dividend and a yield of 4.6%. National Health Investors’s dividend payout ratio (DPR) is 118.71%.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.